Abstract
Continuous ambulatory peritoneal dialysis (CAPD) has come to be extensively used for the treatment of end-stage renal failure in children, and especially infants, such that now more than half of children on dialysis worldwide receive treatment by this means. Peritonitis, however, is commoner in children than in adults receiving treatment, and is a major source of morbidity and treatment failure in children started on CAPD. Only recently has the immunology of the normal peritoneum been studied extensively, with the need to assess the impact of the installation of large volumes of fluid into the peritoneal sac during dialysis. The main phagocytic defences of the peritoneum depend upon a unique set of macrophages which are present free in the peritoneal fluid but also in the submesothelium and in perivascular collections together with B lymphocytes in the submesothelial area. Both the number of macrophages per unit volume and the concentration of opsonic proteins, such as IgG, complement and fibronectin, are reduced to between only 1% and 5% when dialysis fluid is continuously present in the peritoneal sac. In addition, the fluids used for CAPD are toxic to both macrophages and to mesothelial cells. Thus minor degrees of contamination frequently lead to peritonitis and in addition the majority of patients have catheters inserted in their peritoneum which become colonised with organisms capable of producing exopolysaccharide (slime), which promotes adhesion of the organism to the plastic and protects them against phagocytic attack and the penetration of antibiotics. Thus the peritoneum is in a state of continual inflammation, as well as being a markedly more vulnerable site than the normal peritoneum to the entry of organisms. Whether clinical peritonitis appears in this state of chronic contamination probably depends on perturbation in the balance between host defences and the organism. WhilstStaphylococcus epidermidis is the commonest, cause of peritonitis,Staphylococcus aureus and Gram-negative organisms are much more serious and more frequently lead either to temporary catheter removal or discontinuation of dialysis altogether. This review describes, the peritoneal defences in relation to the genesis of peritonitis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Gokal R, Nolph KD (eds) (1994) The textbook of peritoneal dialysis. Kluwer, Dordrecht
Von Lilien T, Salusky IB, Boechat I, Ettenger RB, Fine RN (1987) Five years' experience with continuous ambulatory or continuous cycling peritoneal dialysis in children. J Pediatr 111: 513–518
Alexander SR, Honda M (1993) Continuous peritoneal dialysis for children: a decade of worldwide grwoth and development. Kidney Int 43 [Suppl 40]: S65-S74
Alexander SR, Balfe JW, Harvey E (1994) Peritoneal dialysis in children. In: Gokal R, Nolph KD (eds) The textbook of peritoneal dialysis. Kluwer, Dordrecht, pp 591–637
Gruskin AB, Baluarte HJ, Dabbagh S (1993) Hemodialysis and peritoneal dialysis. In: Edelmann CM Jr (ed) Pediatric nephrology. Little Brown, Boston, pp 827–916
Fine RN, Salusky IB, Hall T, Lucullo L, Jordan SC, Ettenger RB (1983) Peritonitis in children undergoing peritoneal dialysis. Pediatrics 71: 806–809
Warady BA, Campoy SF, Gross SP, Sedman AB, Lum GM (1984) Peritonitis with CAPD and CCPD. j Pediatr 105: 726–730
Powell D, San Luis E, Calvin S, MacDaid T, Potter D (1985) Peritonitis in children undergoing continuous ambulatory peritoneal dialysis. Am J Dis Child 139: 29–32
Watson AR, Vigneaux A, Bannatyne RM, Balfe JW (1986) Peritonitis during continuous peritoneal dialysis in children. Can Med Assoc J 134: 1019–1022
Chesney RW, Zelikovic I (1988) Peritonitis in childhood renal disease. Am J Nephrol 8: 147–160
Mocan H, Murphy AV, Beattie TJ, McAllister TA (1988) Peritonitis in children on continuous ambulatory dialysis. J Infect 16: 243–251
Rubin J, Herrera GA, Collins D (1991) An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 18: 97–102
DiPaolo N, Sacchi G, Buoncristiani U, Rossi P, Gaggiotti E, Alessandrini C, Ibba L, Pucci AM (1986) The morphology of the peritoneum in CAPD patients. In: Maher JF, Winchester JF (eds) Frontiers in peritoneal dialysis. Field Rich, New York, pp 11–19
Dobbie JW, Zaki MA (1987) The ultrastructure of the parietal peritoneum in normal and uremic man and in patients on CAPD. In: Maher JF, Winchester JF (eds) Frontiers in peritoneal dialysis. Field Rich, New York, pp 3–10
Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD (1990) Isolation culture and characterization of human peirtoneal mesothelial cells. Nidney Int 37: 1563–1570
Dobbie JW (1994) Ultrastructure and pathology of the peritoneum in peritoneal dialysis. In: Gokal R, Nolph KD (eds) The textbook of peritoneal dialysis. Kluwer, Dordrecht, pp 17–44
Suassuna J, Glancey G, Das Neves F, Hartley B, Ogg C, Cameron JS (1990) Mesothelial cell and endothelial cell markers of activation in the peritoneal membrane of CAPD patients (abstract). Abstracts of the 4th meeting of the International Society for Peritoneal Dialysis, Kyoto, July 1990, p43
Glancey G, Cameron JS, Ogg CS, Poston S (1993) Adherence ofStaphylococcus aureus to cultures of human peritoneal mesothelial cells. Nephrol Dial Transplant 8: 157–162
Jonjic N, Peri G, Bernasconi S, Sciacca L, Colotta F, Pelicci P, Lanfrancone L, Mantovani A (1992) Expression of adhesion molecules and chemotaxic cytokines in cultured human mesothelial cells. J Exp Med 176: 1165–1174
Mackenzie RK, Coles GA, Williams JD (1990) Eicosanoid synthesis in human peritoneal macrophages stimulated withS. epidermidis. Kidney Int 37: 1316–1324
Rapoport J, Douvdevani A, Conforti A, Zlotnik M, Chaimowitz C (1992) Peritoneal mesothelial cells synthesise IL-1. J Am Soc Nephrol 3: 416
Topley N, Brown Z, Jörres A, Westwick J, Davies M, Coles GA, Williams JD (1993) Human peritoneal mesothelial cells synthesise interleukin-8. Am J Pathol 142: 1876–1886
Li KK, Loetscher P, Williams JD, Topley N (1995) Human peritoneal mesothelial cells (HPMC) synthesise MCP-1 and RANTES: induction by IL-1β and TNFα Nephrol Dial Transplant: (in press)
Vipond MN, Whawell SA, Thomson JN, Dudley HAF (1990) Peritoneal fibrinolytic activity and intraabdominal adhesions. Lancet 335: 1120–1122
Suassuna JHR, Das Neves FC, Hartley RB, Ogg CS, Cameron JS (1994) Immunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD. Kidney Int 46: 443–454
White R, Korthius R, Granger DN (1994) The peritoneal microcirculation in peritoneal dialysis. In: Gokal R, Nolph KD (eds) The textbook of peritoneal dialysis. Kluwer, Dordrecht, pp 45–68
Keane WF, Peterson PK (1984) Host defense mechanisms of the peritoneal cavity and continuous ambulatory peritoneal dialysis. Perit Dial Bull 4: 122–127
Tranaeus A, Heimberger O, Lindholm B (1988) Peritonitis during continuous ambulatory peritoneal dialysis (CAPD): risk factors, clinical severity, and pathogenetic aspects. Perit Dial Int 8: 253–263
Harrison M, Keane W (1989) Host defense mechanisms in chronic ambulatory peritoneal dialysis-associated peritonitis. Semin Dial 2: 117–121
Holmes CJ (1990) CAPD-associated peritonitis: an immunological perspective on causes and interventions. Contrib Nephrol 86: 73–90
Cairns HS (1992) Continuous ambulatory peritoneal dialysis peritonitis: role and treatment of impaired host defenses. Semin Dial 4: 17–19
Holmes CJ (1992) Peritoneal immune defense in continuous ambulatory peritoneal dialysis: clinical relevance and practical implications. Perit Dial Int 13 [Suppl 2]: S278-S281
Churchill DN (1992) CAPD peritonitis: a critical appraisal of prophylatic strategies. Semin Dial 4: 94–100
Holmes CJ (1994) Peritoneal host defense mechanisms in peritoneal dialysis. Kidney Int 46 [Suppl 48]: S58-S70
Coles GA, Lewis SL, Williams JD (1994) Host defence and the effects of solutions on peritoneal cells. In: Gokal R, Nolph KD (eds) The textbook of peritoneal dialysis. Kluwer, Dordrecht, pp 503–528
Verbrugh HA, Keane WF, Hoidal JR, Freiburg MR, Elliott GR, Peterson PK (1983) Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing peritoneal dialysis. J Infect Dis 147: 1018–1029
Goldstein CS, Bomalski JS, Zurier RB, Neilson EG, Douglas SD (1984) Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Kidney Int 26: 733–740
Peterson PK, Gaziano E, Suh HJ, Devalon M, Peterson L, Keane WF (1985) Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages. Infect Immun 49: 212–218
McGregor SJ, Borck JH, Briggs JD, Junor BJR (1987) Bactericidal activity of peritoneal macrophages from continuous ambulatory dialysis patients. Nephrol Dial Transplant 2: 104–108
Davies SJ, Suassuna J, Ogg CS, Cameron JS (1989) Activation of immunocompetent cells in the peritoneum of patients treated with CAPD. Kidney Int 36: 661–668
Eischen A, Duclos B, Schmitt-Goguel M, Rouyer N, Bergerat JP, Hornel M, Oskam R, Oberling F (1994) Human resident peritoneal macrophages: phenotype and biology. Br J Haematol 88: 712–722
Boner G, Mhashilkar AM, Rodruigez-Ortega M, Sharon N (1989) Lectin-mediated nonopsonic phagocytosis of type IEscherichia coli by human peritoneal macrophages of uremic patients treated by peritoneal dialysis. J Leukoc Biol 24: 239–245
Duwe AK, Vas SI, Weatherhead JW (1981) Effects of composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 33: 130–135
Alobaidi HM, Coles GA, Davies M, Lloyd D (1986) Host defence in continuous ambulatory peritoneal dialysis: the effect of dialysate on phagocyte function. Nephrol Dial Transplant 1: 16–21
Cecchin E, Tesio F, Marchi S de (1987) Effect of dialysate on polymorphonuclear leukocytes function in CAPD. Nephrol Dial Transplant 2: 191–192
Topley N, Alobaidi HMM, Davies M, Coles GA, Williams JD, Lloyd D (1988) The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 34: 404–411
Bronswijk H van, Verbrugh HA, Heezius EC, Verkooyen RP, Meulen J van der, Verhoef J (1990) Host defences in CAPD treatment: the effect of dialysate on cell function. Contrib Nephrol 86: 67–72
Jörres A, Topley N, Witowski J, Leberek T, Gahl GM (1992) Impact of peritoneal dialysis solutions on peritoneal immune defense. Perit Dial Int 13 [Suppl 2]: S291-S298
Liberek T, Topley N, Jörres A, Oetersen MM, Coles GA, Gahl GM, Williams JD (1993) Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 65: 260–265
Jörres A (1994) Effect of peritoneal dialysis fluids on leukocyte function. Perit Dial Int 14 [Suppl 3]: S29-S32
Jörres A, Gahl GM, Frei U (1994) Peritoneal dialysis compatibility: does it really matter? Kidney Int 46 [Suppl 48]: S79-S86
Jörres A, Gahl GM, Topley N, Neubauer A, Ludat K, Müller C, Passlick-Heetjen J (1994) In vitro biocompatibility of alternative CAPD fluids: comparison of bicarbonate-buffered and glucosepolymer-based solutions. Nephrol Dial Transplant 9: 785–790
Libereck T, Topley N, Jörres A, Coles GA, Gahl GM, Williams JD (1993) Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. J Am Soc Nephrol 3: 1508–1515
De Fijter CWH, Verbrugh HA, Peters EDJ, Oe PL, Meulen J van der, Verhoef J, Donker AJM (1993) In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. Clin Nephrol 39: 75–80
Rubin J, Lin LM, Lewis R, Cruse J, Bower JD (1983) Host defense mechanisms in continuous ambulatory peritoneal dialysis. Clin Nephrol 20: 140–144
Wiselander AP, Nordin MK, Kjellstrand PTT, Boberg UC, (1991) Cytoxic effects of peritoneal dialysis fluids on cultured fibroblasts L-929. Kidney Int 40: 77–79
Bos HJ, Bronswijk H van, Helmerhorst TJM, Oe PL, Hoefsmit ECM. Beelen RHJ (1988) Distinct subpopulations of elicited human macrophages in peritoneal dialysis patients and women undergoing laparoscopy. A study of peroxidative activity. J Leukoc Biol 43: 172–178
Bronswijk H van, Verbrugh HA, Bos HJ, Heezius ECJM, Pe PL, Meulen J van der, Verhoef J (1989) Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 9: 197–202
Breborowicz A, Rodela H, Oreopoulos D (1992), Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 41: 1280–1285
Bos HJ, Struijk DG, Tuk CW, Veld JC de, Helmerhorst TJM, Hoefsmit ECM, Arisz L, Beelen RHJ (1991). Peritoneal dialysis induces a local sterile inflammatory state and the mesothelial cells in the effluent are related to bacterial peritonitis incidence. Nephron 59: 508–509
Witkowski J, Topley N, Jörres A, Liberek T, Coles GA, Williams JD (1995) Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int (in press)
Jörres A, Jörres D, Topley N, Gahl GM, Mahiout A (1991) Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions. Nephrol Dial Transplant 6: 495–501
Dobbie JW, Anderson JD, Hind C (1994) Long-term effects of peritoneal dialysis on peritoneal morphology. Perit Dial Int 14 [Suppl 3]: S16-S20
Schneble F, Bonzel K-E, Waldherr R, Bachmann S, Roth H, Schärer K (1992) Peritoneal morphology in children treated by continuous ambulatory peritoneal dialysis. Pediatr Nephrol 6: 542–546
Slater ND, Cope GH, Raftery AT (1991) Mesothelial hyperplasia in response to peritoneal dialysis fluid: a morphometric study in the rat. Nephron 58: 466–471
Bennett-Jones DN (1987) Risk factors for peritonitis and technique failure in CAPD: increased age and dialysate IgG protect against peritonitis. Contrib Nephrol 57: 63–68
Bennett-Jones DN, Yewdall VMA, Gillespie CME, Ogg CS, Cameron JS (1989) Strain differences in opsonisation ofStaphylococcus epidermidis. Perit Dial Int 9: 333–339
Vlaanderen K, Bos HJ, Fijter CWH de, Oe LP, Meulen J van der, Verbrugh HA, Beelen RHJ (1991) Short dwell times reduce the local defence mechanism of chronic peritoneal dialysis patients. Nephron 57: 29–35
Yewdall VMA, Bennett-Jones DN, Cameron JS, Williams DG, Ogg CS (1986) Opsonically active proteins in CAPD fluid. In: Maher JF, Winchester JF (eds) Frontiers of peritoneal dialysis. Field Rich, New York, pp 573–578
Vas SL (1983) Microbiologic aspects of chronic ambulatory peritoneal dialysis. Kidney Int 23: 83–92
Verbrugh HA (1990) Organisms causing peritonitis. Contrib Nephrol 85: 39–48
Burke M, Brier ME, Golper TA (1994) Culture negative CAPD patients — the network 9 study. Adv Perit Dial 10: 174–178
Buggy DR, Schaberg, Swartz D (1984) Leukocytic sequestration as a cause of persistentStaphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis. Am J Med 76: 1035–1040
Muijsken MA, Fijter C de, Heezius EJHM, Oe LP, Verhoef J, Verbrugh HA (1991) Intracellular survival of staphylococci in both peritoneal macrophages (PMO) and mesothelial cells (MC) as a possible cause of relapsing peritonitis (abstract). J Am Soc Nephrol 2: 366
Ludlam H, Dickens A, Simpson A, Phillips I (1990) A comparison of four culture methods for diagnosing infection in continuous ambulatory peritoneal dialysis. J Hosp Infect 16: 263–269
Dressler R, Peters AT, Lynn RI (1989) Pseudomonal and candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virus-infected patients. Am J Med 86: 787–790
Kimmel PL Umana WO, Simmens SJ, Watson J, Bosch JP (1993) Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end-stage renal disease. Kidney Int 44: 373–378
Maiorca R, Cantaluppi A, Cancarini GC, Scalamonga A, Broccoli R, Graziani G, Brasa S, Ponticelli C (1986) Prospective controlled trial of a Y connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet II: 642–644
Canadian CAPD clinical trials group (1989) Peritonitis in continuous ambulatory peritoneal dialysis: a multi centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Perit Dial Int 9: 159–163
Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA (1992) Risk of peritonitis and technique failure by CAPD connection technique: a national survey. Kidney Int 42: 967–974
Holley JL, Bernardini J, Piraino B (1994) Infecting organisms in CAPD patients using the Y-set. Am J Kidney Dis 23: 569–573
Garcia-Lopez E, Mendoza-Guevara L, Morales A, Aguilar-Kitzu A, Vicencio LM, Hernandez-Fernandez N (1994) Comparison of peritonitis rates in children on CAPD with spike connector versus two disconnect systems. Adv Perit Dial 10: 300–303
Brown AL, Stephenson JR, Baker LRI, Tabaqchali S (1991) Epidemiology of CAPD-associated peritonitis caused by coagulase-negative staphylococci: comparison of strains isolated from hands, abdominal Tenckhoff catheter exit site and peritoneal fluid. Nephrol Dial Transplant 6: 643–648
Piraino B, Bernardini J, Sorkin M (1987) A five year study of the microbiologic results of exit site infections and peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 10: 281–286
Davies SJ, Ogg CS, Cameron JS, Poston S, Noble WC (1989)Staphylococcus aureus nasal carriage, exite site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 9: 61–64
Luzar MA, Coles GA, Faller B, Slingeneyer A, Dah GD, Briat C, Wone C, Knefati Y, Kessler M, Peluso F (1990)Staphylococcus aureus nasal carriage in continuous ambulatory peritoneal dialysis patients — a link to infection. N Engl J Med 322: 505–509
Luzar MA (1990) Exit site infections in CAPD: a review. Contrib Nephrol 85: 57–66
Piraino B (1990) A review ofStaphylococcus aureus exit site and tunnel infections in peritoneal infections in peritoneal dialysis patients. Am J Kidney Dis 16: 89–95
Scalamonga A, Castelnovo C, Vecchi A de, Ponticelli C (1991) Exit site and tunnel infections in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 18: 674–677
Piraino B, Perlmutter JA, Holley JL, Bernardini J (1992)Staphylococcus aureus peritonitis is associated withStaphylococcus aureus nasal carriage in peritoneal dialysis patients. Perit Dial Int 13 [Suppl 2]: S332-S334
Rutherford PA, Archer L, Gould K, Tapson JS, Venning M, Wilkinson R (1994) Four year experience of gram negative peritonitis in chronic peritoneal dialysis. J Nephrol 6: 159–163
Glancey GR, Cameron JS, Ogg CS (1992) Peritoneal drainage: an important element in host defence against staphylococcal peritonitis in patients in CAPD. Nephrol Dial Transplant 7: 627–631
Chatenoud L (1992) Effects of chronic renal failure on the immune response. In: Cameron JS, Davison AM, Grünfeld J-P, Kerr DNS, Ritz E (eds) Oxford textbook of clinical nephrology. Oxford University Press, London, pp 1312–1316
Chandra RK (1989) Nutritional regulation of immunity and risk of infection in old age. Immunology 67: 141–147
Chan MK, Chow L, Lam SS, Jones B (1988) Peritoneal eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study. Am J Kidney Dis 11: 180–183
Lewis SL, Epps DE van (1987) Neutrophil and monocyte alterations in chronic dialysis patients. Am J Kidney Dis 9: 381–395
Brando B, Galato R, Seveso M, Dommoaruga E, Minetti L (1988) Flow cytometric study of immunocompetent cell phenotypes and phagocytosis in CAPD effluent. Trans Am Soc Artif Intern Organs 34: 414–444
Davies SJ, Yewdall VMA, Ogg CS, Cameron JS (1990) Peritoneal defence mechanisms andStaphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 10: 135–140
Lamperi S, Carozzi S (1990) Immunological defenses in CAPD. Blood Purif 7: 126–143
Lewis SL, Norris PJ, Holmes CJ (1990) Phenotypic characterization of monocytes and macrophages from CAPD patients. Trans Am Soc Artif Intern Organs 36: M575-M577
McGregor SJ, Brock JH, Briggs JD, Junor BJR (1990) Release of hydrogen peroxide and expression of HLA-DR and transferrin receptors by monocytes and peritoncal macrophages from patients undergoing continuous ambulatory peritoneal dialysis and controls. Clin Immunol Immunopathol 56: 151–158
Lewis SL, Norris PJ (1990) Monocyte/macrophage function in CAPD patients. Contrib Nephrol 85: 1–9
Sulowicz W, Hanicki Z, Chichocki T, Zembala M, Ruggiero I, Uracz W (1991) Functional characteristics of peritoneal macrophages of renal failure patients on peritoneal dialysis. Perit Dial Int 11: 265–269
Antonsen S, Pedersen FB, Wang P (1991) Leucocytes in peritoneal dialysis effluents. Perit Dial Int 11: 43–47
Hart PH, Jones CA, Jones KL, Finlay Jones JJ (1993) Reduced secretion of IL-1β by peritoneal cells from patients on CAPD. Immunol Cell Biol 71: 99–107
Lewis R, Ogg CS, Cameron JS, et al. (1995) Leukocytes from the peritoneum of patients maintained on continuous ambulatory dialysis show impaired phagocytosis of opsonisedEscherichia coli. Nephrol Dial Transplant (in press)
Betjes MGH, Tuk CW, Struijk DG, Krediet RT, Arisz L, Beelen RHJ (1993) Antigen-presenting capacity of macrophages and dendritic cells in the peritoneal cavity of patients treated with peritoneal dialysis. Clin Exp Immunol 94: 377–384
McGregor SJ, Brock JH, Briggs JD, Junor BJR (1989) Longitudinal study of peritoneal defense mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 9: 115–119
Lin C-Y, Ku, W-L, Huang T-P (1990) Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients. Am J Nephrol 10: 368–373
Betjes MGH, Tuk CW, Strijk DG, Krediet RT, Arisz L, Hoefsmit ECM, Beelen RHJ (1993) Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study. Kidney Int 43: 641–648
Betjes MGH, Tuk CW, Visser CE, Zemel D, Krediet RT, Arisz L, Beelen RHJ (1994) Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitis. Nephrol Dial Transplant 9: 684–692
Valle MT, Degl'Innocenti ML, Giordano P, Kunkl A, Costantini MT, Perfumo F, Manca F, Gusmano R (1989) Analysis of cellular populations in peritoneal effluents of children on CAPD. Clin Nephrol 32: 235–238
Lewis S, Holmes C (1991) Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. I. Perit Dial Int 11: 14–21
Dunn DL, Barke RA, Ewald DC, Simmonds RL (1987) Macrophages and translymphatic absorption represent the first line of host defence of the peritoneal cavity. Arch Surg 122: 105–110
Dunn DL, Barke DA, Knight NB, Simmonds RL (1985) Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun 49: 257–264
Harvey DM, Morgan AG, Fletcher J (1990) The polymorph neutrophil in CAPD patients. Contrib Nephrol 85: 10–15
Davies SJ (1990) Peritoneal lymphocyte populations in CAPD patients. Contrib Nephrol 85: 16–23
Lewis SL, Kutvirt SG, Cooper CL, Bonner PN, Holmes CJ (1992) Characteristics of peripheral and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients. Perit Dial Int 13 [Suppl 2]: S273-S277
Carozzi S (1990) Lympho-monokine disorders in continuous ambulatory peritoneal dialysis. Contrib Nephrol, 85: 128–139
Fermadez de Castro M, Selgas R, Jimenez C, Bajo MA, Martinez V, Ramon Romero J, Alvaro F de, Vara F (1994) Cell populations present in the nocturnal peritoneal effluent of patients on continuous ambulatory peritoneal dialysis and their relationship with peritoneal function and incidence of peritionitis. Perit Dial Int 14: 265–270
Tucci A, Zubler RH, Campisi S, Cavartorta F, Favre H (1993) In vitro function of peripheral blood and peritoneal B lymphocytes from CAPD patients. Perit Dial Int 13: 84–86
Keane WF, Comty C, Verbrugh HA, Peterson PK (1984) Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int 25: 539–543
Lamperi S, Carozzi S (1986) Defective opsonic activity of peritoneal effluent in continuous ambulatory peritoneal dialysis-importance and prevention (CAPD) Perit Dial Bull 6: 87–92
Goodship THJ, McLachlan SM, Poon TFH, Lloyd S, Ward MK, Kerr DNS (1986) Immunoglobulins in CAPD. In: Maher JF, Winchester JF (eds) Frontiers in peritoneal dialysis. Field Rich, New York, pp 600–603
Khan RH, Klein M, Vas S (1987) Fibronectin in the normal peritoneal fluids of patients on chronic ambulatory dialysis (CAPD) and during peritonitis. Perit Dial Bull 7: 69–73
Coles GA (1990) Immunoglobulin and complement. Contrib Nephrol 85: 24–29
Holmes C, Lewis S (1991) Host defense mechanisms in the peritoneal cavity of continuous ambulatory dialysis patients. II. Humoral defenses. Perit Dial 11: 112–117
Yewdall VMA, Boscoe MJ, Bennett-Jones DN, Cameron JS (1987) Clinical applications of crossed immunoelectrophoresis to the study of complement activation. J Clin Lab Immunol 24: 51–56
Holmes CJ, Lewis SL, Evans RC, Kubey WY, Luneberg P, Mucha D (1989) Periodic elevation of complement activation products in peritoneal dialysis effluent. Trans Am Soc Artif Intern Organs 35: 587–589
Young GA, Kendall S, Brownjohn AM (1993) Complement activation during CAPD. Nephrol Dial Transplant 8: 1372–1375
Goldstein CS, Garrick RE, Polin RA, Gerdes JS, Kolski GB, Neilson EG, Douglas SD (1986) Fibronectin and complement secretion by monocytes and peritoneal macrophages in vitro from patients undergoing continuous ambulatory peritoneal dialysis. J Leukoc Biol 39: 457–464
Zemel D, Koomens GC, Strijk DG, Krediet RT (1993) Fibronectin during CAPD related peritonitis: no indication for intraperitoneal production. Blood Purif 11: 378–383
Schroeder RH, Bakkeren JAJM, Weemaes CMR, Monnens L (1989) IgG2 deficiency in young children treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 9: 201–205
Fivush B, Case M, Lederman H (1989) Hypogammaglobulinemia in children undergoing continuous ambulatory peritoneal dialysis. Pediatr Nephrol 3: 186–188
Hisano S, Miyazaki C, Hatae K, Kaku Y, Yamane I, Ueda K (1992) Immune status of children on continuous ambulatory peritoneal dialysis (CAPD). Pediatr Nephrol 6: 179–181
Katz A, Kashtan C, Greenberg L, Shapiro R, Nevins T, Kim Y (1990) Hypogammaglobulinemia in uremic infants receiving peritoneal dialysis. J Pediatr 117: 258–261
Glancey GR, Cameron JS, Ogg CS, Fijter CWH de, Meulen J van der (1990) Washout kinetics of intraperitoneal IgG in CAPD patients. Nephrol Dial Transplant 5: 78
Nielsen H, Espersen F, Kharazni A, Antonsen S, Ejlersen E, Joffe P, Pedersen FB (1992) Specific opsonic activity for staphylococci in peritoneal dialysis effluent during CAPD. Am J Kidney Dis 20: 372–375
Doran JE, Raynor RH (1981) Fibronectin binding to protein-A containing staphylococci. Infect Immun 33: 683–689
Goldman M, Vandenbeele P, Moulart J, Amraoui Z, Abramowicz D, Nortier J, Vanherweghem J-L, Fiers W (1990) Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis. Am J Kidney Dis 22: 430–435
Lin C-Y, Lin C-C, Huang T-P (1993) Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis. Nephron 63: 404–408
Zemel D, Krediet RT, Koomen GCM, Kortekaas WMR, Geertzen HMG, Berge RJM ten (1994) Interleukin-8 during peritonitis in patients treated with CAPD: an in-vivo model of acute inflammation. Nephrol Dial Transplant 9: 169–174
Zemel D, Imholz ALT, Waart DR de, Dinkla C, Struijk DG, Krediet RT (1994) Appearance of tumor necrosis factor-α and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int 46: 1422–1430
Dasgupta MK, Larabie M, Halloran PF (1994) Interferon gamma levels in peritoneal dialysis effluents: relation to peritonitis. Kidney Int 46: 475–481
Steinhauer HB, Günter B, Schollmeyer P (1985) Stimulation of peritoneal synthesis of vasoactive prostaglandins during peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Invest 15: 1–5
Lin C-Y, Huang T-P (1994) Gene expression and release of interleukin-8 by peritoneal macrophages and polymorphonuclear leukocytes during peritonitis in uremic patients on continuous ambulatory peritoneal dialysis. Nephron 68: 437–441
Topley N, Petersen MM, Mackenzie R, Neubauer A, Stylianou E, Kaever V, Davies M, Coles GA, Jörres A, Williams JD (1994) Human mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. Kidney Int 46: 900–909
Stylianou E, Mackenzie R, Davies M, Coles GA, Williams JD (1990) The interaction of organism, phagocyte and phagocytic cell. Contrib Nephrol 85: 30–39
Topley N, Mackenzie R, Jörres A, Coles GA, Davies M, Williams JD (1992) Cytokine networks in continuous ambulatory peritoneal dialysis: interactions of resident cells during inflammation in the peritoneal cavity. Perit Dail Int 13 [Suppl 2]: S282-S290
Topley N, Williams JD (1994) Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int 46 [Suppl 48]: S71-S78
Gordon DL, Rice JL, Avery VM (1990) Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 9: 191–197
Haagen IA, Heezius HC, Verkooyen RP, Verhoef J, Verbrugh HA (1990) Adherence of peritonitis-causing staphylococci to human peritoneal mesothelial cells. J Infect Dis 161: 266–273
Betjes MGH, Bos HJ, Krediet RT, Arisz L (1991) The mesothelial cells in CAPD effluent and their relation to peritonitis incidence. Perit Dial Int 11: 22–26
Breborowicz A, Rodela H, Pagiamitzis J, Oreopoulos D (1991) Stimulation of mesothelial cells proliferation by endogenous growth factors(s). Perit Dial Int 11: 228–232
Liberek T, Topley N, Luttmann W, Coles GA, Williams JD (1993) Adherence of PMN to cytokine-activated human peritoneal mesothelial cells (HPMC): importance of ICAM-1 (abstract). J Am Soc Nephrol 3: 411
Andreoli SP, Mallett C, Williams K, McAteer JA, Rothlein R, Doerschuk CM (1994) Mechanisms of polymorphonuclear leukocyte mediated peritoneal mesothelial cell injury. Kidney Int 46: 1100–1109
Bosse R, Vestveber D (1994) Only simultaneous blocking of the L-and P-selectin completely inhibits neutrophil migration into mouse peritoneum. Eur J Immunol 24: 3019–3024
Muijksen MA, Heezius HJCM, Verhoef J, Verbrugh HA (1991) Role of mesothelial cells in peritoneal antibacterial defence. J Clin Pathol 44: 600–604
Levy M, Balfe JW, Geary D, Fryer-Keene S, Bannantyne R (1990) Exit-site infection during continuous and cycling peritoneal dialysis in children. Perit Dial Int 10: 31–35
Lubrich-Birkner I, Schollmeyer P, Böhler J (1994) Carrier status for nasal staphylococci does not predict infection in CAPD patients. Adv Perit Dial 10: 154–157
Dasgupta MK, Bettcher KB, Ulan RA, Burns VA, Lam K, Dossetor JB, Costerson JW (1987) Relationship of adherent bacterial biofilms to peritonitis in chronic ambulatory peritoneal dialysis. Perit Dial Bull 7: 168–173
Read RR, Eberwein P, Dasgupta MK, Grant SK, Lam K, Nickel JC, Costerton JW (1989) Peritonitis in peritoneal dialysis: bacterial colonization by biofilm spread along the catheter surface. Kidney Int 35: 614–621
Dasgupta MK, Kowalewaska-Grochowska K, Costerton JW (1992) Biofilm and peritonitis in peritoneal dialysis. Perit Dial Int 13 [Suppl 2]: S322-S325
Holmes CJ (1990) Catheter associated biofilm. Contrib Nephrol 85: 49–56
Marrie TJ, Noble MA, Costerson JW (1983) Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy. J Clin Microsc 18: 1388–1398
Horsmann GB, MacMillan L, Amatnieks Y, et al. (1986) Plasmid profile and slime analysis of coagulase-negative staphylococci from CAPD patients with peritonitis. Perit Dial Bull 6: 195–198
Gray ED, Peters G, Verstegen M, Regelmann WE (1984) Effect of extracellular slime substance fromStaphylococcus epidermidis on the human cellular immune response. Lancet I: 365–367
Lewis R, Ogg CS, Cameron JS, et al. (1995) Staphylococcal extracellular slime substance inhibits peritoneal macrophage phagocytosis in patients maintained on continuous ambulatory dialysis. (Submitted for publication)
Evans RC, Holmes CJ (1987) Effect of vancomycin hydrochloride onStaphylococus epidermidis biofilm associated with silicone clastomer. Antimicrob Agents Chemother 31: 889–894
Sombolos K, Vas S, Ritkin O, Ayiomamitis A, McNamce P, Oreopoulos D (1986) Propionibacteria isolates and asymptomatic infections of the peritoneal effluent in CAPD patients. Nephrol Dial Transplant 1: 175–178
Dryden MS, Talsania H, Rodgers J, Bayston R, Phillips I (1993) Serological response to coagulase-negative staphylococci in patients with peritonitis on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 12: 87–92
Coles GA, Minors SJ, Horton JK, Fifield R, Davies M (1989) Can the risk of peritonitis be predicted for new continuous ambulatory peritoneal dialysis (CAPD) patients? Perit Dial Int 9: 69–72
Holmes CJ, Lewis SL, Kubey WY, Epps DE van (1990) Comparison of peritoneal white blood cell parameters from continuous ambulatory dialysis patients with high or low incidence of peritonitis. Am J Kidney Dis 15: 258–264
Coles GA, Alobaidi HMM, Topley N, Davies M (1987) Opsonic activity of dialysis effluent predicts those at risk ofStaphylococcus epidermidis peritonitis. Nephrol Dial Transplant 2: 359–365
Zemel D, Struick DG, Krediet RT (1989) No relationship between dialysate IgG and peritonitis incidence in CAPD (abstract). Abstracts of the European Dialysis and Transplant Association Göteborg, 1989, p 109
Anwar N, Hutchison J, Manos J, Uttley L, Brenchley P, Gokal R (1992) Peritoneal dialysate IgG/C3 levels do not predict peritonitis (abstract). J Am Soc Nephrol 3: 406
Steen S, Brenchley P, Manot J, Pumphrey R, Gokal R (1986) Opsonizing capacity of peritoneal fluid and relationship to peritonitis in CAPD patients. In: Maher JF, Winchester JF (eds) Frontiers in peritoneal dialysis. Field Rich, New York, pp 565–568
Olivas E, Jímenez JL, Serrano A, Caseiro G, López A, Sánchez Tárrega L (1990) Défecit de immunoglobulinas en líquido peritoneal en pacientes urémicos en DPCA con alta incidencia de peritonitis. Nefrología 8: 42–46
De Vecchi AF, Kopple JD, Young GA, Nolph KD, Vonesh EF, Castelnovo C, Dichiro J, Nissenson A, Borwnjohn AM, Prowant B, Algrim C (1990) Plasma and dialysate immunoglobulin G in continuous ambulatory peritoneal dialysis patients: a multicenter study. Am J Nephrol 10: 451–456
Nagano M, Tagawa H, Yamakodo M, Umezu M, Saito H (1992) Can serum and dialysate IgG levels predict the risk of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients? In: Ota K, Maher J, Winchester J, Hirszel P (eds) Current concepts in peritoneal dialysis. Excerpta Medica, Amsterdam, pp 310–314
Kuroda M, Kawano M, Itoh M, Kinoshita T, Hatakeyama S, Koni I, Takeda R, Kusunoki N (1992) Significance of immunoprotein measurements in peritoneal dialysis effluents in CAPD peritonitis. In: Ota K, Maher J, Winchester J, Hirszel P (eds) Current concepts in peritoneal dialysis. Excerpta Medica, Amsterdam, pp 310–314
Ludlam HA, Young AE, Berry AJ, Phillips I (1989) The prevention of infection withStaphylococcus aureus in continuous ambulatory peritoneal dialysis. J Hosp, Infect 14: 293–301
Ludlam H, Dryden M, Wing AJ, Phillips I (1990) Prevention of peritonitis in continuous ambulatory peritoneal dialysis (letter). Lancet 335: 1161
Swartz R, Messana J, Starmann B, Weber M, Reynolds J (1991) PreventingStaphylococcus aureus infection during chronic peritoneal dialysis. J Am Soc Nephrol 2: 1085–1091
Zimmerman SW, Johnson CA (1989) Rifampin use in peritoneal dialysis. Perit Dial Int 9: 241–243
Moncrief JW, Popovich (1994) Moncrief-Popovich catheter: implantation technique and clinical results. Perit Dial Int 14 [Suppl 3]: S56-S58
Sciatizzi A, Strippoli P (1986) Prophylaxis againstStaphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 22: 392–396
Poole Warren LA, Hallett MD, Hone PW, Burden SH, Farrell PC (1992) Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial. Clin Nephrol 35: 198–206
Fattom A, Scheerson R, Watson DC, Karakawa WW, Fitzgerald D, Pastan I, Li X, Shiloach J, Bryla DA, Robbins JB (1993) Laboratory and clinical evaluation of conjugate vaccines composed ofStaphylococcus type 5 and 8 capsular polysaccharides bound toPseudomonas aeruginosa recombinant exoprotein A. Infect Immun 61: 1023–1032
Welsh P, Fattom A, Sigmon J, Schneerson R, Robbins J, Moore J (1993) Safety and immunogenicity of a conjugate vaccine againstStaphylococcus aureus type 5 capsular polysaccharide in hemodialysis patients. J Am Soc Nephrol 4: 259
Keane WF, Bergeron B, Pence T, Peterson PK (1987) Nephrology ed Am Davison “Challenges for continuous ambulatory peritoneal dialysis”. Proceedings of the Xth International Congress of Nephrology, Balliere Tindall, London, pp 1255–1267
Lamperi S, Carozzi S (1989) Peritonitis prevention in continuous ambulatory peritoneal dialysis by intraperitoneal IgG. Contrib Nephrol 70: 325–329
Billing AG, Frölich D, Konecny G, Schildberg FW, Machleidt W, Priitz H, Jochum M (1994) Local serum applications: restoration of sufficient host defense in human peritonitis. Eur J Clin Invest 24: 28–35
Lamperi S, Carozzi S (1988) Interferon-γ (IFN-γ) as an in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis. Am J Kidney Dis 11: 225–230
Carozzi S, Nasini MG, Schelotto C, Caviglia PM, Barocci S, Cantaluppi A, Salit M (1990) Modulation of peritoneal macrophage antimicrobial activity by dialysis fluid Ca++ and 1,25(OH)2D3 in CAPD patients. ASAIO Trans 36: 467–469
Chan PCK, Ip MSM, Pun KK (1991) 1,25 dihydrocholecalciferol and peritoneal macrophage chemotaxis in patients on continuous ambulatory peritoneal dialysis. Nephron 59: 434–439
Fijter CWH de, Verbrugh HA, Oe LP, Peters EDJ, Meulen J van der, Donker AJM, Verhoef J (1992) Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int 42: 947–950
Brunkhorst R, Mahiout A, Schindler R, Wrenger E, Krautzig H, Koch KM (1993) Effects of nightly intermittent peritoneal dialysis (NIPD) on interleukin-1 receptor antagonist in peritoneal macrophages. J Am Soc Nephrol 4: 398
Paterson AD, Bishop MC, Morgan AG, Burden RP (1986) Removal and replacement of Tenckhoff catheter at a single operation: successful treatment of resistent peritonitis in continuous ambulatory peritoneal dialysis. Lancet II: 1245–1247
Innes A, Burden RP, Finch RG, Morgan AG (1994) Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double blind clinical trial. Nephrol Dial Transplant 9: 797–799
Young GA, Taylor A, Kendall S, Brownjohn AM (1990) Longitudinal study of proteins in plasma and dialysate during continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 10: 257–261
Steen S, Brenchley P, Manos J, Pumphrey R, Gokal R (1986) Opsonising capacity of peritoneal fluid and relationship of peritonitis in CAPD patients. In: Maher JF, Winchester JF (eds) Frontiers in peritoneal dialysis. Field Rich, New York, pp 565–568
Author information
Authors and Affiliations
Additional information
Based in part on an address given to the European Society of Paediatric Nephrology in Heidelberg, Germany, October 1993
Rights and permissions
About this article
Cite this article
Cameron, J.S. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis. Pediatr Nephrol 9, 647–662 (1995). https://doi.org/10.1007/BF00860966
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00860966